Stonehouse Jon P 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Dec 17, 2024
Insider Transaction Report
Form 4
Stonehouse Jon P
Director
Transactions
- Tax Payment
Common Stock
2024-12-14$7.53/sh−27,525$207,263→ 1,101,019 total
Holdings
- 20,000(indirect: By Trust)
Common Stock
- 20,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the Reporting Person.